{"id":23986,"date":"2026-11-15T23:40:31","date_gmt":"2026-11-15T22:40:31","guid":{"rendered":"https:\/\/mon.uvic.cat\/TR2Lab\/?p=23986"},"modified":"2026-11-16T23:56:53","modified_gmt":"2026-11-16T22:56:53","slug":"rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer","status":"publish","type":"post","link":"https:\/\/mon.uvic.cat\/TR2Lab\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\/","title":{"rendered":"RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_3 1_3 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:33.333333333333%;--awb-margin-top-large:0px;--awb-spacing-right-large:5.76%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:5.76%;--awb-width-medium:33.333333333333%;--awb-order-medium:0;--awb-spacing-right-medium:5.76%;--awb-spacing-left-medium:5.76%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-1\"><p><strong>Authors: <\/strong>Llop-Guevara A, Pellegrino AB, Pimentel I, Villacampa G, Solinas C, Torres-Esquius S, Campanini N, Simonetti S, Tommasi C, Serra O, Corian\u00f2 M, Boggiani D, Michiara M, Minari R, Bortesi B, Rapacchi E, Dieci MV, Lambertini M, Zoppoli G, Schirone A, Casarini C, Cretella E, Cortesi L, Silini EM, Saura C, Willard-Gallo K, Boisson A, Musolino8 A, Serra V, Balma\u00f1a J, <a href=\"https:\/\/mon.uvic.cat\/TR2Lab\/team-view\/cristina-cruz-zambrano\/\">Cruz C<\/a><\/p>\n<p><strong>DOI: <\/strong>https:\/\/doi.org\/10.1038\/s41523-026-00920-5<\/p>\n<p><strong>Keywords: <\/strong>Biomarkers, Cancer, Oncology, Breast Cancer, Genetics<\/p>\n<p><a href=\"https:\/\/www.nature.com\/articles\/s41523-026-00920-5#Abs1\">Read More<\/a><\/p>\n<\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_2_3 2_3 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:66.666666666667%;--awb-margin-top-large:0px;--awb-spacing-right-large:2.88%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:2.88%;--awb-width-medium:66.666666666667%;--awb-order-medium:0;--awb-spacing-right-medium:2.88%;--awb-spacing-left-medium:2.88%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-2\"><p>Advances in <strong>breast cancer (BC) therapy<\/strong> are limited by <em>the absence of well-established biomarkers for DNA-damage targeted treatments<\/em>.<\/p>\n<p>We evaluated the predictive and prognostic value of <em>homologous recombination repair (HRR) deficiency (HRD) by RAD51 nuclear foci<\/em> and <em>stromal tumour-infiltrating lymphocytes (TILs)<\/em> in early-stage BC patients with <em>suspected germline susceptibility<\/em>.<\/p>\n<p>Among 291 patients, HRD by RAD51 was found in 78.4% of tumours, and 69.8% had low TILs (&lt;30%). In 178 patients treated with neoadjuvant chemotherapy, pathologic complete response (pCR) was higher in those with HRD vs HRR-proficient (HRP) tumours (52.3% vs 36.4%); RAD51 remained independently associated with pCR (<i>p<\/i>\u2009=\u20090.03).<\/p>\n<p><strong>Overall survival (OS) favoured HRD<\/strong>, with 5-year OS of 89.2% vs 82.8% in HRP (<i>p<\/i>\u2009=\u20090.009), with stronger evidence in triple-negative TILs-low disease (<i>p<\/i>\u2009=\u20090.005). These findings support <strong>RAD51-based HRD<\/strong> assessment as a predictive and prognostic biomarker that may guide treatment decisions in early-stage BC.<\/p>\n<p><a href=\"https:\/\/mon.uvic.cat\/TR2Lab\/files\/2026\/11\/Captura-de-pantalla-2026-11-15-233635.png\"><img decoding=\"async\" class=\" wp-image-23987 aligncenter\" src=\"https:\/\/mon.uvic.cat\/TR2Lab\/files\/2026\/11\/Captura-de-pantalla-2026-11-15-233635-286x300.png\" alt=\"\" width=\"624\" height=\"655\" srcset=\"https:\/\/mon.uvic.cat\/TR2Lab\/files\/2026\/11\/Captura-de-pantalla-2026-11-15-233635-200x209.png 200w, https:\/\/mon.uvic.cat\/TR2Lab\/files\/2026\/11\/Captura-de-pantalla-2026-11-15-233635-286x300.png 286w, https:\/\/mon.uvic.cat\/TR2Lab\/files\/2026\/11\/Captura-de-pantalla-2026-11-15-233635-400x419.png 400w, https:\/\/mon.uvic.cat\/TR2Lab\/files\/2026\/11\/Captura-de-pantalla-2026-11-15-233635.png 780w\" sizes=\"(max-width: 624px) 100vw, 624px\" \/><\/a><\/p>\n<\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":896,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[585,614],"tags":[],"class_list":["post-23986","post","type-post","status-publish","format-standard","hentry","category-585","category-research-line-in-breast-cancer"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer - TR2Lab - Tissue Repair and Regeneration<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mon.uvic.cat\/TR2Lab\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer - TR2Lab - Tissue Repair and Regeneration\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mon.uvic.cat\/TR2Lab\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"TR2Lab - Tissue Repair and Regeneration\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-15T22:40:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-16T22:56:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mon.uvic.cat\/TR2Lab\/files\/2026\/11\/Captura-de-pantalla-2026-11-15-233635.png\" \/>\n\t<meta property=\"og:image:width\" content=\"780\" \/>\n\t<meta property=\"og:image:height\" content=\"817\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"alexiaanamaria\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"alexiaanamaria\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\\\/\"},\"author\":{\"name\":\"alexiaanamaria\",\"@id\":\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/#\\\/schema\\\/person\\\/f136eb3885af4fd4b724997c4730b90d\"},\"headline\":\"RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer\",\"datePublished\":\"2026-11-15T22:40:31+00:00\",\"dateModified\":\"2026-11-16T22:56:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\\\/\"},\"wordCount\":2468,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/files\\\/2026\\\/11\\\/Captura-de-pantalla-2026-11-15-233635-286x300.png\",\"articleSection\":[\"2026\",\"Research line in Breast Cancer\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\\\/\",\"url\":\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\\\/\",\"name\":\"RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer - TR2Lab - Tissue Repair and Regeneration\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/files\\\/2026\\\/11\\\/Captura-de-pantalla-2026-11-15-233635-286x300.png\",\"datePublished\":\"2026-11-15T22:40:31+00:00\",\"dateModified\":\"2026-11-16T22:56:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/#\\\/schema\\\/person\\\/f136eb3885af4fd4b724997c4730b90d\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/files\\\/2026\\\/11\\\/Captura-de-pantalla-2026-11-15-233635.png\",\"contentUrl\":\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/files\\\/2026\\\/11\\\/Captura-de-pantalla-2026-11-15-233635.png\",\"width\":780,\"height\":817},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/#website\",\"url\":\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/\",\"name\":\"TR2Lab - Tissue Repair and Regeneration\",\"description\":\"Tissue Repair and Regeneration Laboratory\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/#\\\/schema\\\/person\\\/f136eb3885af4fd4b724997c4730b90d\",\"name\":\"alexiaanamaria\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9125633662b6ca48361d6d0656cc620d1c02598473a73ce4b2b4d96ebdaeda13?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9125633662b6ca48361d6d0656cc620d1c02598473a73ce4b2b4d96ebdaeda13?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9125633662b6ca48361d6d0656cc620d1c02598473a73ce4b2b4d96ebdaeda13?s=96&d=mm&r=g\",\"caption\":\"alexiaanamaria\"},\"url\":\"https:\\\/\\\/mon.uvic.cat\\\/TR2Lab\\\/author\\\/alexiaanamaria\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer - TR2Lab - Tissue Repair and Regeneration","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mon.uvic.cat\/TR2Lab\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\/","og_locale":"en_US","og_type":"article","og_title":"RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer - TR2Lab - Tissue Repair and Regeneration","og_url":"https:\/\/mon.uvic.cat\/TR2Lab\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\/","og_site_name":"TR2Lab - Tissue Repair and Regeneration","article_published_time":"2026-11-15T22:40:31+00:00","article_modified_time":"2026-11-16T22:56:53+00:00","og_image":[{"width":780,"height":817,"url":"https:\/\/mon.uvic.cat\/TR2Lab\/files\/2026\/11\/Captura-de-pantalla-2026-11-15-233635.png","type":"image\/png"}],"author":"alexiaanamaria","twitter_card":"summary_large_image","twitter_misc":{"Written by":"alexiaanamaria","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mon.uvic.cat\/TR2Lab\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\/#article","isPartOf":{"@id":"https:\/\/mon.uvic.cat\/TR2Lab\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\/"},"author":{"name":"alexiaanamaria","@id":"https:\/\/mon.uvic.cat\/TR2Lab\/#\/schema\/person\/f136eb3885af4fd4b724997c4730b90d"},"headline":"RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer","datePublished":"2026-11-15T22:40:31+00:00","dateModified":"2026-11-16T22:56:53+00:00","mainEntityOfPage":{"@id":"https:\/\/mon.uvic.cat\/TR2Lab\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\/"},"wordCount":2468,"commentCount":0,"image":{"@id":"https:\/\/mon.uvic.cat\/TR2Lab\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/mon.uvic.cat\/TR2Lab\/files\/2026\/11\/Captura-de-pantalla-2026-11-15-233635-286x300.png","articleSection":["2026","Research line in Breast Cancer"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/mon.uvic.cat\/TR2Lab\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/mon.uvic.cat\/TR2Lab\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\/","url":"https:\/\/mon.uvic.cat\/TR2Lab\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\/","name":"RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer - TR2Lab - Tissue Repair and Regeneration","isPartOf":{"@id":"https:\/\/mon.uvic.cat\/TR2Lab\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mon.uvic.cat\/TR2Lab\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\/#primaryimage"},"image":{"@id":"https:\/\/mon.uvic.cat\/TR2Lab\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/mon.uvic.cat\/TR2Lab\/files\/2026\/11\/Captura-de-pantalla-2026-11-15-233635-286x300.png","datePublished":"2026-11-15T22:40:31+00:00","dateModified":"2026-11-16T22:56:53+00:00","author":{"@id":"https:\/\/mon.uvic.cat\/TR2Lab\/#\/schema\/person\/f136eb3885af4fd4b724997c4730b90d"},"breadcrumb":{"@id":"https:\/\/mon.uvic.cat\/TR2Lab\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mon.uvic.cat\/TR2Lab\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mon.uvic.cat\/TR2Lab\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\/#primaryimage","url":"https:\/\/mon.uvic.cat\/TR2Lab\/files\/2026\/11\/Captura-de-pantalla-2026-11-15-233635.png","contentUrl":"https:\/\/mon.uvic.cat\/TR2Lab\/files\/2026\/11\/Captura-de-pantalla-2026-11-15-233635.png","width":780,"height":817},{"@type":"BreadcrumbList","@id":"https:\/\/mon.uvic.cat\/TR2Lab\/rad51-based-homologous-recombination-deficiency-is-associated-with-treatment-response-and-survival-in-early-breast-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mon.uvic.cat\/TR2Lab\/"},{"@type":"ListItem","position":2,"name":"RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer"}]},{"@type":"WebSite","@id":"https:\/\/mon.uvic.cat\/TR2Lab\/#website","url":"https:\/\/mon.uvic.cat\/TR2Lab\/","name":"TR2Lab - Tissue Repair and Regeneration","description":"Tissue Repair and Regeneration Laboratory","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mon.uvic.cat\/TR2Lab\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/mon.uvic.cat\/TR2Lab\/#\/schema\/person\/f136eb3885af4fd4b724997c4730b90d","name":"alexiaanamaria","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9125633662b6ca48361d6d0656cc620d1c02598473a73ce4b2b4d96ebdaeda13?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9125633662b6ca48361d6d0656cc620d1c02598473a73ce4b2b4d96ebdaeda13?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9125633662b6ca48361d6d0656cc620d1c02598473a73ce4b2b4d96ebdaeda13?s=96&d=mm&r=g","caption":"alexiaanamaria"},"url":"https:\/\/mon.uvic.cat\/TR2Lab\/author\/alexiaanamaria\/"}]}},"jetpack_publicize_connections":[],"jetpack_shortlink":"https:\/\/wp.me\/p6byuV-6eS","jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/mon.uvic.cat\/TR2Lab\/wp-json\/wp\/v2\/posts\/23986","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mon.uvic.cat\/TR2Lab\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mon.uvic.cat\/TR2Lab\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mon.uvic.cat\/TR2Lab\/wp-json\/wp\/v2\/users\/896"}],"replies":[{"embeddable":true,"href":"https:\/\/mon.uvic.cat\/TR2Lab\/wp-json\/wp\/v2\/comments?post=23986"}],"version-history":[{"count":5,"href":"https:\/\/mon.uvic.cat\/TR2Lab\/wp-json\/wp\/v2\/posts\/23986\/revisions"}],"predecessor-version":[{"id":23992,"href":"https:\/\/mon.uvic.cat\/TR2Lab\/wp-json\/wp\/v2\/posts\/23986\/revisions\/23992"}],"wp:attachment":[{"href":"https:\/\/mon.uvic.cat\/TR2Lab\/wp-json\/wp\/v2\/media?parent=23986"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mon.uvic.cat\/TR2Lab\/wp-json\/wp\/v2\/categories?post=23986"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mon.uvic.cat\/TR2Lab\/wp-json\/wp\/v2\/tags?post=23986"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}